Intratect 50 g/l infusionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

intratect 50 g/l infusionsvæske, opløsning

biotest pharma gmbh - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 g/l

Gammanorm 165 mg/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

gammanorm 165 mg/ml injektionsvæske, opløsning

octapharma ab - normalt immunglobulin, humant - injektionsvæske, opløsning - 165 mg/ml

Octagam 50 mg/ml infusionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

octagam 50 mg/ml infusionsvæske, opløsning

octapharma ab - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 mg/ml

Uman Big 180 IE/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

uman big 180 ie/ml injektionsvæske, opløsning

kedrion s.p.a. - hepatitis b immunglobulin, humant - injektionsvæske, opløsning - 180 ie/ml

Novabig 180 IE/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

novabig 180 ie/ml injektionsvæske, opløsning

paranova danmark a/s - hepatitis b immunglobulin, humant - injektionsvæske, opløsning - 180 ie/ml

Octagam 100 mg/ml infusionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

octagam 100 mg/ml infusionsvæske, opløsning

octapharma ab - normalt immunglobulin, humant - infusionsvæske, opløsning - 100 mg/ml

Subcuvia 160 mg/ml injektionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

subcuvia 160 mg/ml injektionsvæske, opløsning

baxalta innovations gmbh - normalt immunglobulin, humant - injektionsvæske, opløsning - 160 mg/ml

Uplizna Europeiska unionen - danska - EMA (European Medicines Agency)

uplizna

horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - immunosuppressiva - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.

Nanogam 50 mg/ml infusionsvæske, opløsning Danmark - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

nanogam 50 mg/ml infusionsvæske, opløsning

prothya biosolutions netherlands b.v. - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 mg/ml

Abecma Europeiska unionen - danska - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiske midler - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.